PP_1170x120_10-25-21

COVID-19 vaccine

Panel endorses widespread use of Pfizer COVID-19 vaccine in the U.S.

Panel endorses widespread use of Pfizer COVID-19 vaccine in the U.S.

WASHINGTON— A committee of top U.S. vaccine scientists recommended Thursday that the Food and Drug Administration authorize the first COVID-19 vaccine for Americans. This endorsement paves the way for a final decision by the FDA and mass vaccinations to begin within days in thousands of front-line heath care workers and nursing homes residents. After an

Today’s FDA panel meeting could lead to Pfizer getting vaccine emergency use okay

Today’s FDA panel meeting could lead to Pfizer getting vaccine emergency use okay

WASHINGTON — Commissioner Stephen Hahn said ahead of  today’s meeting of the Food and Drug Administration’s vaccine advisory panel is “an important day for all of America.” Pfizer’s COVID-19 vaccine faces one last hurdle as it races to become the first shot greenlighted in the U.S. — a panel of experts who will carefully scrutinize

Moderna begins study of COVID-19 vaccine in adolescents

Moderna begins study of COVID-19 vaccine in adolescents

CAMBRIDGE, Mass. — Moderna announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the company’s vaccine candidate against COVID-19, in adolescents ages 12 to less than 18. The study is being conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of

U.K. authorizes Pfizer, BioNTech’s COVID-19 vaccine for emergency use

U.K. authorizes Pfizer, BioNTech’s COVID-19 vaccine for emergency use

LONDON — According to various published reports, the U.K. has became the first Western nation to grant emergency-use authorization for a COVID-19 vaccine, clearing a shot developed by Pfizer and BioNTech to be distributed in limited numbers wnext week. The two-shot vaccine is also being reviewed by the Food and Drug Administration in the U.S., where a

Follett offers options for vaccine storage

Follett offers options for vaccine storage

  EASTON, Pa. — Immunization with a safe and effective COVID-19 vaccine is a critical component of the strategy to reduce COVID-19-related illnesses and restore societal functioning. Establishing the proper cold chain to ensure effectiveness of these vaccines will be critical. Engineered for precise temperature control, Follett refrigerators and freezers deliver: Precise temperature control down

Moderna to seek FDA approval for coronavirus vaccine

Moderna to seek FDA approval for coronavirus vaccine

WASHINGTON —  Moderna announced it would file Monday for regulatory clearance — a critical milestone that brings the United States a step closer to having two coronavirus vaccines before the end of the year. Moderna’s vaccine was 94% effective at preventing illness in a 30,000-person clinical trial, the company said — a performance that exceeds

CNBC: COVID-19 vaccine for five federal agencies coming soon

CNBC: COVID-19 vaccine for five federal agencies coming soon

NEW YORK — According to a report from  CNBC’s Berkeley Lovelace Jr., five federal agencies have started telling employees they could receive Pfizer or Moderna’s COVID-19 vaccine in as little as eight weeks as the U.S. prepares to distribute the potentially life-saving doses across the country, said a person with first-hand knowledge of the plan. Essential federal workers

Kinney Drugs to be part of COVID-19 vaccine solution

Kinney Drugs to be part of COVID-19 vaccine solution

GOUVERNEUR, N.Y. – Kinney Drugs has announced that it will be part of that public COVID-19 vaccination solution once it is available, through its long-standing relationship with Managed Health Care Associates (MHA). Through this relationship and in partnership with the Centers for Disease Control and Prevention (CDC), Kinney pharmacists will be able to provide safe,

Pfizer seeking emergency use of its COVID-19 vaccine

Pfizer seeking emergency use of its COVID-19 vaccine

NEW YORK  — Pfizer and BioNTech SE announced they will submit a request Friday to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end of

Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint

Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint

CAMBRIDGE, Mass. — Moderna announced on Monday that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. This study, known

Pfizer reports COVID-19 vaccine 90% effective in Phase 3 trial

Pfizer reports COVID-19 vaccine 90% effective in Phase 3 trial

NEW YORK — Pfizer announced on Monday that the vaccine the company jointly developed with BioNTech was 90% effective in preventing COVID-19 infections in ongoing Phase 3 trials. Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings. “The first set of

HDA releases policy principles for COVID-19 vaccine distribution

HDA releases policy principles for COVID-19 vaccine distribution

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration. HDA highlights four priority areas for vaccine distribution:

Vaccine makers will not be rushed

Vaccine makers will not be rushed

NEW YORK — The effort to develop a safe and effective vaccine for COVID-19 has been an all-hands-on-deck approach ever since the virus began wreaking havoc across the globe earlier this year. But it seems now, with the presidential election less than two months away — and with President Trump promising a vaccine “very soon”